| Characteristics of Pulmonary Arterial Hypertension Patients and Evaluation of Factors Affecting Treatment Response and Survival | Bilge YIlMAZ KARA, Benan MüSEllİM, Gül ÖNGEN | 1–11 |
| Evaluation of Clinical Course and Treatment Success of Elderly Patients with Community- Acquired Pneumonia Hospitalized and Treated in Accordance with the Treatment Guidelines | Özge ORAL TAPAN, Utku TAPAN | 12–19 |
| Are Patients With Tuberculous Pleurisy With Low ADA Levels Different from Those With High ADA Levels? | İbrahim Onur ALICI, Ceyda ANAV, Melike YÜKSEL YAVUZ, Melih BÜYÜKŞİRİN, Filiz GÜLDAVAL | 20–26 |
| Endobronchial Treatment for Bronchopleural Fistula After Lung Resection | Hasan Oğuz KAPICIBAŞI, Selami Volkan BAYSUNGUR, Abidin Levent ALPAY | 27–34 |
| The Association of the SUVMax Value Measured on PET-CT with the Stage and Survival in Nonsmall Cell Lung Cancers | Coşkun DOĞAN, Nesrin KIRAL, Elif TORUN PARMAKSIZ, Ali FİDAN, Sevda ŞENER CÖMERT, Benan ÇAĞLAYAN, Berrin ZİNNET ERASLAN | 35–42 |
| Association Between Plasminogen Activator Inhibitor type-1 Gene (PAI-1) Polymorphism and Pulmonary Embolism | Gülay CEYLAN, Canan H. HASANOĞLU, Filiz ÇURLACI KARASU, Mükremin ER | 43–49 |
| Thousand Face of Cavitary Lesions: Journey from Diagnosis of Pulmonary Embolism to the Lung Cancer | Güllistan KARADENİZ, Gülru POLAT, Aysu AYRANCI, Damla SERÇE UNAT, Ömer Selim UNAT | 50–54 |